There were no significant differences between COVID-19 and the control group at baseline in all patients in NT-proBNP values (4.82 ± 5.79 ng/mL vs. 3.21 ± 3.31 ng/mL, p = 0.28). The gene discussed is NPPB; the disease is COVID-19.